Intravascular administration of liposomes offers several advantages over traditional drug delivery mechanisms. First, it allows for targeted drug delivery, directing therapeutic agents specifically to the disease site and sparing healthy tissue. This targeted approach often results in increased therapeutic efficacy and reduced systemic toxicities. Liposomes can provide a controlled and sustained drug release, which can maintain the drug concentration within the therapeutic window for an extended period. Due to their biocompatibility and biodegradability, liposomes are usually well-tolerated, leading to minimal adverse effects. Moreover, liposomes can encapsulate both hydrophilic and hydrophobic drugs, enabling a wide variation of drugs to be delivered using this method. They also have the potential to cross the blood-brain barrier, making them a promising tool for treating neurological disorders.
Add comment
Comments